Project Grant R03AG084918
Award Date
9/1/24
Completion Date
6/30/26
Dollars Obligated
$150K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports research into the role of senescent cells in brain aging and Alzheimer's disease and related dementias (ADRD). The $654,238 award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2026, aims to generate high-resolution spatial omics data from ADRD brains and corresponding mouse models to identify molecular changes in the...
This Project Grant award for $2,398,590.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to investigate the role of brain microcirculation and capillary endothelial cell energetics in the development of vascular cognitive impairment and dementia (VCID) observed in Alzheimer's disease (AD) and AD-related dementias. The...
This federal Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $169,560 to the Regents of the University of Michigan to research ways to reverse neural network dysfunction in Alzheimer's disease (AD) and related dementias. The key objectives are to: Identify disrupted gene expression in inhibitory interneurons within the hippocampus and cortex of human AD brains to uncover therapeutic targets for restoring cognitive function....
This $146,922 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to determine the gene expression landscape that distinguishes hippocampal engram cells (neural ensembles representing individual memories) from non-engram cells, and how this landscape changes with age and in an Alzheimer's disease mouse model. The research will use cutting-edge techniques like single-nuclear RNA sequencing and RNA interference to identify key molecular...
This federal Project Grant award R36AG087310 was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to the University of Southern California (USC) in the amount of $103,304. The award, effective August 1, 2024 through July 31, 2025, will support research to identify specific neuron cell types within the medial temporal lobe that are susceptible to Alzheimer's disease (AD) pathology. The project aims to use advanced viral tracing and microscopy...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to identify the molecular mechanisms underlying the contribution of cerebrovascular disease (CVD) pathologies to Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) in older adults. The $654,910 award to Rush University Medical Center will leverage existing clinical, pathological, and multi-omics data from two studies (ROS and MAP) to...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $2,173,794 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on enhancing brain resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis. The project aims to explore the mechanisms by which adult hippocampal neurogenesis cooperates with brain-derived neurotrophic factor (BDNF) to potentially slow cognitive decline in...
This $528,876 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will enable Emory University to investigate the cis- and trans-genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). The key products and services to be delivered include: Developing new analytical tools to integrate transcriptome-wide association studies (TWAS) and proteome-wide association studies...
This federal Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $831,583 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on characterizing microvascular impairment in adults with elevated genetic risk for Alzheimer's disease. The long-term goal of the work is to elucidate the physiological mechanisms through which the APOE-E4 genetic variant contributes to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $161,500.00 to investigate the role of perineuronal nets (PNN) in the development of postoperative delirium in aged mice. The research aims to test the hypothesis that changes in PNN and parvalbumin-positive neurons coincide with delirium-like cognitive impairment in aged mice subjected to anesthesia, surgery, and intensive care unit (ICU)-like conditions. The project will also examine whether...